Buscar
PolyPid Ltd
PYPDAñadir a la lista de seguimiento
5.020USD
-0.030-0.59%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
91.38MCap. mercado
PérdidaP/E TTM
Más Datos de PolyPid Ltd Compañía
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Información de PolyPid Ltd
Símbolo de cotizaciónPYPD
Nombre de la empresaPolyPid Ltd
Fecha de salida a bolsaJun 26, 2020
Director ejecutivoAkselbrad (Dikla Czaczkes)
Número de empleados57
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 26
Dirección18 Hasivim Street, P.O Box 7126
CiudadPETAH TIKVA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal4917002
Teléfono972747195700
Sitio Webhttps://www.polypid.com
Símbolo de cotizaciónPYPD
Fecha de salida a bolsaJun 26, 2020
Director ejecutivoAkselbrad (Dikla Czaczkes)
Ejecutivos de PolyPid Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mrs. Anat Tsour Segal
Mrs. Anat Tsour Segal
Independent Director
Independent Director
--
--
Dr. Shaul Mukhtar, Ph.D.
Dr. Shaul Mukhtar, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ms. Dalit Hazan
Ms. Dalit Hazan
Senior Vice President - Research and Development and Regulatory Affairs
Senior Vice President - Research and Development and Regulatory Affairs
--
--
Mr. Nir Dror
Mr. Nir Dror
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de PolyPid Ltd?
Los cinco principales accionistas de PolyPid Ltd son: Dr. Yechezkel Barenholz, Ph.D.
¿Cuántas instituciones poseen acciones de PolyPid Ltd (PYPD)?
A fecha de 2026Q1, 33 instituciones poseen acciones de PolyPid Ltd, con un valor de mercado combinado de aproximadamente 6.41M, lo que representa el 33.61% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 15623.00.